High-dose topotecan, melphalan, and cyclophosphamide (TMC) with stem cell support: a new regimen for the treatment of advanced ovarian cancer.
Donato ML, Gershenson DM, Wharton JT, Ippoliti CM, Aleman AS, Bodurka-Bevers D, Bevers MW, Burke TW, Levenback CF, Wolf JK, Freedman RS, Bast RC Jr, Gajewski JL, Champlin RE.
Donato ML, et al. Among authors: bodurka bevers d.
Gynecol Oncol. 2001 Sep;82(3):420-6. doi: 10.1006/gyno.2001.6326.
Gynecol Oncol. 2001.
PMID: 11520135
Clinical Trial.